2023 - National Conferences and Events, listed by Name
SAMO - Workshop: Invited Talk on Subgroup Analyses in Lymphoma Trials
2023 - Ad Hoc Reviewer, listed by Journal Name
Cancer incidence and mortality in 23,000 patients with type 1 diabetes in the UK: long-term follow-up
2023 - Ad Hoc Reviewer, listed by Journal Name
Study protocol for a multicentre, non-randomised, phase 2 study of multidrug chemotherapy with high-dose methotrexate, procarbazine, and vincristine followed by reduced-dose, whole-brain radiation and high-dose cytarabine therapy for primary central nervous system lymphoma in elderly patients with d
2023 - Ad Hoc Reviewer, listed by Journal Name
Outcomes Associated with Time to High-Dose Methotrexate Clearance in Patients with Central Nervous System Lymphoma
2022 - Ad Hoc Reviewer, listed by Journal Name
Detection of circulating tumor DNA in plasma of patients with primary large B-cell lymphoma of the sanctuary sites by digital droplet PCR
2022 - Ad Hoc Reviewer, listed by Journal Name
Patient Reported and Clinical Outcomes After High-dose Chemotherapy and Autologous Stem Cell Transplantation in PCNSL
2022 - Ad Hoc Reviewer, listed by Journal Name
CAR-T Use in Solid Organ Transplant Recipients: a Case Report and Literature Review
2022 - Ad Hoc Reviewer, listed by Journal Name
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
2022 - Ad Hoc Reviewer, listed by Journal Name
Considerations when introducing electronic patient-reported outcome data capture in multicentre oncology randomised controlled trials COMMENT
